Recently, Naama Kanarek and colleagues reported that histidine ammonia lyase (HAL), the rate‐limiting enzyme of the histidine degradation pathway, contributed to the sensitivity of cancer cells to MTX by competitive consumption of THF (Kanarek et al., 2018). Here, HAL is linked to cancer.